NeueHealth, Inc. (NYSE:NEUE - Get Free Report) saw a significant growth in short interest during the month of August. As of August 31st, there was short interest totaling 12,800 shares, a growth of 43.8% from the August 15th total of 8,900 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily volume of 7,000 shares, the short-interest ratio is currently 1.8 days. Based on an average daily volume of 7,000 shares, the short-interest ratio is currently 1.8 days. Approximately 0.4% of the shares of the stock are sold short.
Institutional Trading of NeueHealth
Several large investors have recently made changes to their positions in NEUE. Skandinaviska Enskilda Banken AB publ bought a new position in NeueHealth in the second quarter valued at about $201,000. PenderFund Capital Management Ltd. bought a new position in NeueHealth in the first quarter valued at about $197,000. Finally, Northern Trust Corp boosted its holdings in NeueHealth by 66.8% in the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company's stock valued at $242,000 after acquiring an additional 13,074 shares during the last quarter. Institutional investors own 63.88% of the company's stock.
NeueHealth Price Performance
Shares of NEUE stock traded down $0.19 during trading hours on Thursday, hitting $6.58. 3,443 shares of the company's stock were exchanged, compared to its average volume of 15,611. The stock's 50-day moving average is $6.74 and its 200-day moving average is $6.68. The stock has a market cap of $59.38 million, a price-to-earnings ratio of -0.41 and a beta of 0.58. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66.
NeueHealth (NYSE:NEUE - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, topping the consensus estimate of ($4.77) by $3.09. The business had revenue of $209.08 million for the quarter, compared to the consensus estimate of $249.50 million. Equities research analysts forecast that NeueHealth will post -9.13 earnings per share for the current fiscal year.
NeueHealth Company Profile
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Featured Articles
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.